Skip to main content
Skip to navigation

Featured Profile: Dongsheng Duan

Dongsheng Duan

University of Missouri medical researcher Dr. Dongsheng Duan is improving the future for young adults with muscular disease.

Duan’s major research interest is in understanding and treating Duchenne muscular dystrophy (DMD), a devastating disease that usually leads to death in early adulthood. His work on the topic, which has spanned many years, has focused on the molecular and cellular biology of the disease gene, the disease mechanism and possible genetic therapies for the disease. In an exciting development, Duan was part of a team that identified a key genetic sequence which is instrumental in causing the symptoms of DMD. Using their findings, the scientists successfully treated dogs with the disease and are working toward a treatment for humans.

In addition to his medical investigations, Duan’s work involves inspiring future generations of scientists. He invites high school students into his lab to give them hands-on experience conducting research. “We need to give kids an opportunity to see what real science is,” he says.

Since his arrival to the University of Missouri in 2002, Dr. Duan has brought in more than 22 million dollars in research funding, mostly from the NIH. For his many achievements, Duan has received numerous recognitions including an “Outstanding New Investigator” award from the American Society of Gene Therapy.

Dr. Dongsheng Duan is Margaret Proctor Mulligan Professor in Medical Research at the School of Medicine. He also has a joint appointment in the department of biomedical sciences, a unit of the College of Veterinary Medicine.

Click here to download a PDF of this story.

Related Initiative(s):
One Health/One Medicine